Stem Cell Educator Therapy in Type 2 Diabetes

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Type 2 Diabetes
Interventions
DEVICE

Stem Cell Educator

For the treatment, commonly the left (or right) median cubital vein, a patient's blood is passed through a Blood Cell Separator that isolates the lymphocytes from the blood according to the recommended protocol by manufacture; consequently, the collected lymphocytes were transferred into the Stem Cell Educator and treated by CB-SC; after that, the educated cells return the blood back to the patient via a dorsal vein of hand. During the MCS+ collection, the whole blood flow rate was maintained at 35 mL/min. The whole procedure was scheduled for 6 \~ 7 hrs.

Trial Locations (1)

250031

General Hospital of Jinan Military Command, Jinan

All Listed Sponsors
collaborator

Chinese government

UNKNOWN

collaborator

Jinan Tianhe Stem Cell Biotechnologies Co Ltd

UNKNOWN

lead

University of Illinois at Chicago

OTHER

NCT01415726 - Stem Cell Educator Therapy in Type 2 Diabetes | Biotech Hunter | Biotech Hunter